Roger Crystal, Chief Executive Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 26,759 shares at $13.28 ($355K) on 2019-01-07, disclosed to the SEC on 2019-01-08.
Open-market sale of $355k OPNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |